Literature DB >> 26049760

Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis.

Ulf Klein1, Nicole Heise.   

Abstract

PURPOSE OF REVIEW: B-cell tumors originating from the transformation of germinal center B cells frequently harbor genetic mutations, leading to constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway. The present review highlights recent insights into the roles of separate NF-κB transcription factors in germinal center B-cell development and discusses implications of the results for germinal center lymphomagenesis. RECENT
FINDINGS: Understanding how aberrant NF-κB activation promotes tumorigenesis requires the understanding of the role of NF-κB in the tumor-precursor cells. Despite extensive knowledge on NF-κB biology, the function of this complex signaling pathway in the differentiation of germinal center B cells is largely unknown. The present review will discuss recent findings that revealed distinct roles of separate NF-κB transcription factors during the germinal center reaction in the context of germinal center lymphomagenesis. Most notably, a single NF-κB subunit, c-REL, was found to be required for the maintenance of the germinal center reaction and was associated with the activation of a metabolic program that promotes cell growth.
SUMMARY: Identifying the biological roles of the separate NF-κB transcription factor subunits in germinal center biology will help to better understand the pathogenic consequences of their constitutive activation in B-cell tumors. This knowledge may be exploited for the development of targeted antitumor therapies aimed at inhibiting selectively those components of aberrant NF-κB activity which contribute to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26049760      PMCID: PMC4459530          DOI: 10.1097/MOH.0000000000000160

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  79 in total

Review 1.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

2.  Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas.

Authors:  Jane Houldsworth; Adam B Olshen; Giorgio Cattoretti; Gerard B Donnelly; Julie Teruya-Feldstein; Jing Qin; Nallasivam Palanisamy; Yingjing Shen; Katerina Dyomina; Marina Petlakh; Qiulu Pan; Andrew D Zelenetz; Riccardo Dalla-Favera; R S K Chaganti
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

Review 3.  Clonal selection and learning in the antibody system.

Authors:  K Rajewsky
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

Review 4.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.

Authors:  Kevin R Bushell; Yukyoung Kim; Fong Chun Chan; Susana Ben-Neriah; Andrew Jenks; Miguel Alcaide; Daniel Fornika; Bruno M Grande; Sarah Arthur; Randy D Gascoyne; Christian Steidl; Ryan D Morin
Journal:  Blood       Date:  2014-12-02       Impact factor: 22.113

6.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.

Authors:  F Köntgen; R J Grumont; A Strasser; D Metcalf; R Li; D Tarlinton; S Gerondakis
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

7.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

8.  Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.

Authors:  Thomas F E Barth; Josée I Martin-Subero; Stefan Joos; Christiane K Menz; Cornelia Hasel; Gunhild Mechtersheimer; Reza M Parwaresch; Peter Lichter; Reiner Siebert; Peter Möoller
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

9.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

10.  Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors:  Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  7 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

2.  Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.

Authors:  Angélica María Gamboa-Cedeño; Mariángeles Castillo; Wenming Xiao; Thomas A Waldmann; Stella Maris Ranuncolo
Journal:  J Cancer Res Clin Oncol       Date:  2019-04-02       Impact factor: 4.553

3.  T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells.

Authors:  Sara L Stone; Jessica N Peel; Christopher D Scharer; Christopher A Risley; Danielle A Chisolm; Michael D Schultz; Bingfei Yu; André Ballesteros-Tato; Wojciech Wojciechowski; Betty Mousseau; Ravi S Misra; Adedayo Hanidu; Huiping Jiang; Zhenhao Qi; Jeremy M Boss; Troy D Randall; Scott R Brodeur; Ananda W Goldrath; Amy S Weinmann; Alexander F Rosenberg; Frances E Lund
Journal:  Immunity       Date:  2019-05-07       Impact factor: 31.745

4.  Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development.

Authors:  Nilushi S De Silva; Michael M Anderson; Amanda Carette; Kathryn Silva; Nicole Heise; Govind Bhagat; Ulf Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

5.  Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b.

Authors:  Sunglim Cho; Hyang-Mi Lee; I-Shing Yu; Youn Soo Choi; Hsi-Yuan Huang; Somaye Sadat Hashemifar; Ling-Li Lin; Mei-Chi Chen; Nikita D Afanasiev; Aly Azeem Khan; Shu-Wha Lin; Alexander Y Rudensky; Shane Crotty; Li-Fan Lu
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919

Review 6.  Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies.

Authors:  Ruth Kennedy; Ulf Klein
Journal:  Cells       Date:  2018-10-30       Impact factor: 6.600

7.  Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.

Authors:  Veronique Della-Valle; Damien Roos-Weil; Laurianne Scourzic; Enguerran Mouly; Zakia Aid; Walaa Darwiche; Yann Lecluse; Frederik Damm; Sylvie Mémet; Thomas Mercher; Said Aoufouchi; Florence Nguyen-Khac; Olivier A Bernard; Hussein Ghamlouch
Journal:  Blood Cancer J       Date:  2020-03-13       Impact factor: 11.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.